452PDSafety, antitumor activity, and pharmacokinetics (PK)...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

452PDSafety, antitumor activity, and pharmacokinetics (PK) of pamiparib (BGB-290), a PARP1/2 inhibitor, in patients (pts) with advanced solid tumours: Updated phase I dose-escalation/expansion results

Voskoboynik, M, Mileshkin, L, Gan, H, Millward, M, Au-Yeung, G, Meniawy, T M, Kichenadasse, G, Zhang, K, Zhang, M, Mu, S, Lickliter, J D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.014
Date:
October, 2019
File:
PDF, 81 KB
2019
Conversion to is in progress
Conversion to is failed